The useful and thorough review by Professor Openshaw and Dr Walzl (October 1999 JRSM, pp. 495±499) raises questions whose answers may contribute to our understanding of the genesis not only of asthma but also of cot death and even cystic ®brosis. What it is that determines a tendency towards T1 rather than T2 responses or vice versa to antigen challenge is likely to be part of the answer, and particularly the role of mycobacteria (known to be adjuvants to some kinds of immune response) and smokingÐan important association of respiratory illness in infancy and of cot death. Is it possible that some components of burned tobacco leaves directly affect the immune response in early life, even in utero; and what was it about certain measles and respiratory syncytial ss vaccines that seems to have exacerbated subsequent infection with these viruses? When I worked in Manchester/Salford (the latter once the chronic bronchitic centre of the world) I noticed that a very high proportion of older infants admitted with wheezing bronchitis were strongly sensitive to house-dust mite, exhibited considerable eosinophilia and came from districts where many of the houses had for a century been overcrowded with inadequate hygiene facilitiesÐi.e. breeding grounds for house-dust mite. Not all these children became asthmatics. Another admitted with acute respiratory illness exhibited high fever, wheezing and a considerably raised polymorph count and some of them did go on to develop typical asthma. It would appear that in¯ammation of the lower respiratory tract in young children with relatively narrow airways causes wheezing from turbulent air¯ow resulting from a critical reduction in boreÐwhatever the type of in¯ammation. It is not safe to assume that relief of wheezing by pharmacological relaxation of what could be normal muscle tone in the airways necessarily means that it was caused by muscle spasm rather than the obstructive thickening of the lining so often found post mortem in asthma.
Developmental immunology is in its infancy and needs systematic exploration for which the opportunity is granted by the monitoring of immunization. It has already been shown that vulnerable babies over-react to such procedures in terms of cortisol production and temperature. Does BCG vaccination, for instance, modify the response to toxoid or live virus vaccines? Two of my own children became permanently`allergic' to the plaster used to cover the site of smallpox vaccination. It is not only genetically determined immunode®ciency that deserves study; Dr Charles Janeway maintained that such de®ciency arti®cially induced was actually protective against the encephalopathy caused by the lymphocytic choriomeningitis virus. If the gut ora affects immune responsiveness, a Gram-negative¯ora tending to switch on T1 responses, one might expect exclusive breast-feeding to have the reverse effect. Professor Eridani presents cell therapy in the form of stem cells for the treatment of other neurodegenerative disorders, such as Alzheimer's disease. However, one needs to be cautious of the potential applications of cell therapy. Transplantation of primary fetal tissue into people with Parkinson's disease has been successful in alleviating some symptoms but does not seem to affect the clinical progression of the diseaseÐi.e. transplanted cells do not even completely replace cell functions lost in the`region of interest'. In Alzheimer's disease there is a more generalized loss of tissue throughout the brain, so that it is hard to envisage where one might place cells in patients' brains. Just replacing the brain cells may not be adequate; such cells would need to relearn the functions of the lost cells. In rats, functional outcome is improved following striatal lesions when the animals are taught to`use the transplant' 1 .
Finally, the use of human stem cells to augment the processes of regeneration/repair of the human nervous system is only one of many approaches under investigation. Other techniques include xenografting, transplantation of genetically modi®ed cells, novel techniques of growth factor delivery and new surgical techniques such as ablation of the subthalamic nucleus. It is likely that a combination of the many techniques currently under investigation, perhaps with stem cells, will ultimately allow us to manipulate central nervous system regeneration.
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